Endothelial dysfunction is reversible in helicobacter pylori-positive subjects

American Journal of Medicine

Volumn 124, Issue 12, 2011, Pages 1171-1174

  Blum, Arnon ^a,b,c   Tamir, Snait ^d   Mualem, Keren ^c   Ben Shushan, Rotem Shelly ^d   Keinan Boker, Lital ^e   Paritsky, Maya ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Poriya Hospital   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^e UNIVERSITY OF HAIFA   (Israel)

Author keywords

Cardiovascular prevention; Endothelial function; Helicobacter pylori

Indexed keywords

ANTIBIOTIC AGENT; INTERLEUKIN 6; PROTON PUMP INHIBITOR;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD FLOW; BLOOD VESSEL DIAMETER; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPEPSIA; ENDOTHELIAL DYSFUNCTION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; VASCULITIS; WAIST CIRCUMFERENCE;

ANTI-BACTERIAL AGENTS; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED;

EID: 81855184472     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.08.015     Document Type: Article

References (21)

1. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979 (Pubitemid 27152782)
2. R. Ross Atherosclerosisan inflammatory disease N Engl J Med 340 1999 115 126
3. M.A. Mendall, P.M. Goggin, and N. Molineaux Relation of Helicobacter pylori infection and coronary heart disease Br Heart J 71 1994 437 439 (Pubitemid 2068912)
4. D.P. Strachan, M.A. Mendall, and D. Carrington Relation of Helicobacter pylori infection to 13 year mortality and incident ischemic heart disease in the Caerphilly Prospective Heart Disease Study Circulation 98 1998 1286 1290 (Pubitemid 28443391)
5. D.H. Thom, J.T. Grayston, D.S. Siscovick, S.P. Wang, N.S. Weiss, and J.R. Daling Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease JAMA 268 1992 68 72
6. Y.F. Zhou, M.B. Leon, and M.A. Waclawiw Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy N Engl J Med 335 1996 624 630 (Pubitemid 26277952)
7. D.S. Celermajer, K.E. Sorensen, and V.M. Gooch Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
8. M. Aslan, Y. Nazligul, M. Horoz, C. Bolukbas, and F.F. Bolukbas Serum paraoxanase-1 activity in Helicobacter pylori infected subjects Atherosclerosis 196 2008 270 274
9. E.Z. Jia, F.J. Zhao, and B. Hao Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis Lipids Health Dis 8 2009 59
10. A. Prasad, J. Zhu, J.P. Halcox, M.A. Waclawiw, S.E. Epstein, and A.A. Quyyumi Predisposition to atherosclerosis by infections: role of endothelial dysfunction Circulation 106 2 2002 184 190 (Pubitemid 34761297)
11. T. Oshima, R. Ozono, and Y. Yano Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects J Am Coll Cardiol 45 2005 1219 1222 (Pubitemid 40523140)
12. H.S. Akbas, S. Basyigit, and I. Suleymanlar The assessment of carotid intima media thickness and serum paraoxonase 1 activity in Helicobacter pylori positive subjects Lipids Health Dis 9 2010 92 98
13. K. Adachi, N. Arima, and T. Takashima Pulse wave velocity and cardiovascular risk factors in subjects with Helicobacter pylori infection J Gastroenterol Hepatol 18 2003 771 777 (Pubitemid 36936567)
14. A. Hoffmeister, D. Rothenbacher, and G. Bode Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile Arterioscler Thromb Vasc Biol 21 2001 427 432 (Pubitemid 32199126)
15. I. Szabo, S. Brutsche, and F. Tombola Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for biological activity EMBO J 18 1999 5517 5527 (Pubitemid 29486371)
16. J.M. Reyrat, V. Pelicic, E. Papini, C. Montecucco, R. Rappuolo, and J.L. Telford Towards deciphering the Helicobacter pylori cytoxin Mol Microbiol 34 1999 197 204 (Pubitemid 29486238)
17. N.P. Tobin, G.T. Henehan, and R.P. Murphy Helicobacter pylori induced inhibition of vascular endothelial cell functions: a role for VacA-dependent nitric oxide reduction Am J Physiol Heart Circ Physiol 295 2008 1403 1413
18. S. Aydemir, H. Eren, I.O. Tekin, F.A. Harmandar, N. Demircan, and M. Cabuk Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels Mediators Inflamm 2010 2010 685903
19. M. Haghazali, M. Molaei, and R. Mashayekhi Proinflammatory cytokines and thrombomodulin in patients with peptic ulcer disease and gastric cancer, infected with Helicobacter pylori Indian J Pathol Microbiol 54 1 2011 103 106
20. T. Bayraktaroglu, A.S. Aras, and S. Aydemir Serum levels of tumor necrosis factor alpha, interleukin 6 and interleukin 8 are not increased in dyspeptic patients with Helicobacter pylori-associated gastritis Mediators Inflamm 13 1 2004 25 28 (Pubitemid 38621646)
21. N. Saleh, B. Svane, J. Jensen, L.O. Hansson, M. Nordin, and P. Torvall Stent implantation but not pathogen burden, is associated with plasma C reactive protein and interleukin 6 levels after percutaneous coronary intervention in patients with stable angina pectoris Am Heart J 149 5 2005 876 882 (Pubitemid 40718885)